This study is evaluating the feasibility and short term smoking cessation outcomes of an automated smoking cessation intervention delivered via mobile phone text messaging as an adjunct to Varenicline in a primary care setting.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
152
Usual care plus motivational text messages sent via Mobile Phone. All participants receive the active medication, Varenicline.
Usual Care. All participants receive the active medication, Varenicline.
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Point Prevalence of 7-day Tobacco Abstinence Biochemically Validated by Exhaled CO < 10ppm at Visit 3 (12 Weeks After Target Quit Day)
Time frame: 12 weeks
Sustained Abstinence at the 12-week Follow up
Time frame: 12 weeks
Number of Days of Varenicline Use
Time frame: 12 weeks
Number of Active Smoking Cessation Activities Used
Number of activities completed out of 6
Time frame: 12 weeks
Continuous Lapse-free Tobacco Abstinence From 4 Weeks to 12 Weeks, Biochemically Validated at Visit 2 and Visit 3.
Time frame: 12 weeks
Time (in Days) to Relapse After the Target Quit Day
Time frame: 12 weeks
Total Score on the Positive Smoking Cessation Activities Measure
Total score for 6 items (scored 0-3). Total score range 0-18.
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.